Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 991 AL 1005

Enzymology of Pyrimidine Metabolism and Neurodegeneration

Vincenzetti S, Polzonetti V, Micozzi D, Pucciarelli S.

Curr Med Chem. 2016;23(14):1408-31. doi: 10.2174/0929867323666160411125803.

Omega-3 fatty acids for the treatment of dementia

Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A.

Cochrane Database Syst Rev. 2016 Apr 11;4(4):CD009002. doi: 10.1002/14651858.CD009002.pub3.

[Supra-on state freezing of gait: two case reports]

Gallardo-Alcaniz MJ, Cabello-De la Rosa JP, Bravo-Gomez JJ, Diaz-Gomez S, Vaamonde-Gamo J.

Rev Neurol. 2016 Apr 16;62(8):357-60.

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's Disease

Song J, Kim J.

Front Aging Neurosci. 2016 Mar 30;8:65. doi: 10.3389/fnagi.2016.00065. eCollection 2016.

Consequences of lead exposure, and it's emerging role as an epigenetic modifier in the aging brain

Eid A, Zawia N.

Neurotoxicology. 2016 Sep;56:254-261. doi: 10.1016/j.neuro.2016.04.006. Epub 2016 Apr 8.

Evidence for the heterotetrameric structure of the adenosine A2A-dopamine D2 receptor complex

Casadó-Anguera V, Bonaventura J, Moreno E, Navarro G, Cortés A, Ferré S, Casadó V.

Biochem Soc Trans. 2016 Apr 15;44(2):595-600. doi: 10.1042/BST20150276.

Optogenetic approaches to evaluate striatal function in animal models of Parkinson disease

Parker KL, Kim Y, Alberico SL, Emmons EB, Narayanan NS.

Dialogues Clin Neurosci. 2016 Mar;18(1):99-107. doi: 10.31887/DCNS.2016.18.1/kparker.

Weight Gain following Pallidal Deep Brain Stimulation: A PET Study

Sauleau P, Drapier S, Duprez J, Houvenaghel JF, Dondaine T, Haegelen C, Drapier D, Jannin P, Robert G, Le Jeune F, Vérin M.

PLoS One. 2016 Apr 12;11(4):e0153438. doi: 10.1371/journal.pone.0153438. eCollection 2016.

Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants

Lopez G, Bayulkem K, Hallett M.

Acta Neurol Scand. 2016 Oct;134(4):242-9. doi: 10.1111/ane.12546. Epub 2016 Jan 6.

Potential applications of stress solutes from extremophiles in protein folding diseases and healthcare

Jorge CD, Borges N, Bagyan I, Bilstein A, Santos H.

Extremophiles. 2016 May;20(3):251-9. doi: 10.1007/s00792-016-0828-8. Epub 2016 Apr 12.

Stressing Out Hsp90 in Neurotoxic Proteinopathies

Inda C, Bolaender A, Wang T, Gandu SR, Koren J 3rd.

Curr Top Med Chem. 2016;16(25):2829-38. doi: 10.2174/1568026616666160413141350.

Imaging Systemic Dysfunction in Parkinson's Disease

Borghammer P, Knudsen K, Brooks DJ.

Curr Neurol Neurosci Rep. 2016 Jun;16(6):51. doi: 10.1007/s11910-016-0655-4.

Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases

Cacciatore I, Ciulla M, Fornasari E, Marinelli L, Di Stefano A.

Expert Opin Drug Deliv. 2016 Aug;13(8):1121-31. doi: 10.1080/17425247.2016.1178237. Epub 2016 May 3.

Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease

Kraemmer J, Smith K, Weintraub D, Guillemot V, Nalls MA, Cormier-Dequaire F, Moszer I, Brice A, Singleton AB, Corvol JC.

J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1106-11. doi: 10.1136/jnnp-2015-312848. Epub 2016 Apr 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias